Search your stocks

Share

Profile

INDSWFTLABInd-Swift Laboratories Ltd.

104.11(-1.61%)

1W: -2.43%

1M: +3.64%

1Y: +5.18%

Financials

Charts

YoY Net Sales

Operating Margin

EPS Growth

Pros & Cons

POSITIVES

Revenue growth peaked in 202403, indicating strong demand and market positioning.
Net profit surged to 238.82 Cr in 202403 showcasing effective cost management.
Improved gross margins in recent quarters suggest better pricing power and cost efficiency.

NEGATIVES

Recent quarters show declining revenue, especially in 202406 and 202409, raising concerns about sustainability.
Operating profit turned negative in 202403 indicating underlying operational challenges.
Significant drop in net profit to 0.01 Cr in 202412 raises red flags about future profitability.

Quarterly Results Data

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		289.71	287.51	393.33	33.17	11.96	8.67	138.24	152.73
Expenses		258.34	270.43	431.84	43.33	24.38	23.56	128.11	156.96
Operating Profit		31.37	17.08	-38.50	-10.16	-12.42	-14.89	10.13	-4.23
Other Income		7.40	7.11	25.25	11.14	13.01	13.81	4.46	14.58
Interest		21.14	21.05	-11.47	0.17	0.41	0.11	-26.76	1.15
Depreciation		13.19	13.56	12.67	0.25	0.22	0.25	7.44	6.68
Profit Before Tax		38.59	24.08	373.29	0.91	0.60	-1.07	230.46	10.48
Tax		6.93	4.67	134.47	-0.03	0.18	-1.08	8.19	1.71
Net Profit		31.66	19.42	238.82	0.94	0.41	0.01	222.27	8.77
Eps in Rs		5.36	3.29	40.42	0.16	0.07	0	32.96	1.28